- Home
- ABEO vs NEWT Comparison
ABEO vs NEWT Comparison
Compare ABEO & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- NEWT
- Stock Information
- Founded
- ABEO 1974
- NEWT 1998
- Country
- ABEO United States
- NEWT United States
- Employees
- ABEO N/A
- NEWT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- ABEO Health Care
- NEWT Finance
- Exchange
- ABEO Nasdaq
- NEWT Nasdaq
- Market Cap
- ABEO 256.9M
- NEWT 306.7M
- IPO Year
- ABEO 1980
- NEWT N/A
- Fundamental
- Price
- ABEO $5.93
- NEWT $10.40
- Analyst Decision
- ABEO Strong Buy
- NEWT Hold
- Analyst Count
- ABEO 6
- NEWT 4
- Target Price
- ABEO $18.00
- NEWT $14.00
- AVG Volume (30 Days)
- ABEO 870.0K
- NEWT 194.3K
- Earning Date
- ABEO 08-11-2025
- NEWT 07-28-2025
- Dividend Yield
- ABEO N/A
- NEWT 7.34%
- EPS Growth
- ABEO N/A
- NEWT 27.62
- EPS
- ABEO N/A
- NEWT 1.92
- Revenue
- ABEO N/A
- NEWT $352,584,000.00
- Revenue This Year
- ABEO N/A
- NEWT N/A
- Revenue Next Year
- ABEO $323.51
- NEWT $13.51
- P/E Ratio
- ABEO N/A
- NEWT $5.38
- Revenue Growth
- ABEO N/A
- NEWT 23.06
- 52 Week Low
- ABEO $3.93
- NEWT $9.12
- 52 Week High
- ABEO $7.32
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- ABEO 45.53
- NEWT 45.56
- Support Level
- ABEO $6.10
- NEWT $10.25
- Resistance Level
- ABEO $6.24
- NEWT $11.34
- Average True Range (ATR)
- ABEO 0.29
- NEWT 0.31
- MACD
- ABEO -0.09
- NEWT -0.05
- Stochastic Oscillator
- ABEO 4.26
- NEWT 25.23
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.